(0.01%) 5 018.87 points
(0.13%) 37 951 points
(0.19%) 15 635 points
(-0.32%) $78.75
(3.11%) $1.992
(-0.44%) $2 300.90
(-0.33%) $26.66
(-0.03%) $954.65
(0.38%) $0.937
(0.57%) $11.09
(0.36%) $0.801
(-1.22%) $92.13
@ $8.06
Išleistas: 14 vas. 2024 @ 22:17
Grąža: -9.80%
Ankstesnis signalas: vas. 14 - 18:43
Ankstesnis signalas:
Grąža: 0.62 %
Live Chart Being Loaded With Signals
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins...
Stats | |
---|---|
Šios dienos apimtis | 75 375.00 |
Vidutinė apimtis | 868 831 |
Rinkos kapitalizacija | 1.07B |
EPS | $0.320 ( 2024-04-30 ) |
Kita pelno data | ( $0.0400 ) 2024-06-05 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 16.91 |
ATR14 | $0.0260 (0.36%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-23 | Hulse William Frank Iv | Sell | 8 896 | Common Stock |
2024-04-08 | Hulse William Frank Iv | Sell | 8 896 | Common Stock |
2024-03-01 | Puhy Dorothy E | Buy | 0 | |
2024-03-01 | Olson Tiffany | Buy | 0 | |
2024-03-13 | Hulse William Frank Iv | Sell | 20 381 | Common Stock |
INSIDER POWER |
---|
97.68 |
Last 95 transactions |
Buy: 35 462 522 | Sell: 808 933 |
Tūris Koreliacija
MiMedx Group Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
MiMedx Group Inc Koreliacija - Valiuta/Žaliavos
MiMedx Group Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $321.48M |
Bruto pelnas: | $266.84M (83.01 %) |
EPS: | $0.400 |
FY | 2023 |
Pajamos: | $321.48M |
Bruto pelnas: | $266.84M (83.01 %) |
EPS: | $0.400 |
FY | 2022 |
Pajamos: | $267.84M |
Bruto pelnas: | $219.53M (81.96 %) |
EPS: | $-0.270 |
FY | 2021 |
Pajamos: | $258.62M |
Bruto pelnas: | $215.33M (83.26 %) |
EPS: | $-0.0932 |
Financial Reports:
No articles found.
MiMedx Group Inc
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a semi-permeable protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications; and AMNIOBURN a semi-permeable protective barrier allograft used in the treatment of partial-thickness and full-thickness burns, as well as lead product includes mdHACM, a micronized form of AMNIOFIX, supplied in powder form. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.